Total Payments
$6,528
2024 Payments
$3,568
Companies
3
Transactions
33
Medicare Patients
13
Medicare Billing
$321.25
Payment Breakdown by Category
Travel$3,219 (49.3%)
Research$2,046 (31.3%)
Food & Beverage$1,263 (19.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,219 | 11 | 49.3% |
| Unspecified | $2,046 | 14 | 31.3% |
| Food and Beverage | $1,263 | 8 | 19.3% |
Payments by Type
General
$4,482
19 transactions
Research
$2,046
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ModernaTX, Inc. | $2,960 | 10 | $0 (2023) |
| SANOFI PASTEUR INC. | $2,046 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,522 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,568 | 23 | SANOFI PASTEUR INC. ($2,046) |
| 2023 | $2,960 | 10 | ModernaTX, Inc. ($2,960) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $560.74 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $292.33 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $247.36 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $107.06 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $97.78 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $89.64 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $71.24 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.94 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.94 | General |
| 02/28/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $78.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/28/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $66.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/28/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $53.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/28/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $41.68 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $720.55 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $638.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $160.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $73.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $37.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $37.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | In-kind items and services | $19.80 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/27/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $5.35 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/26/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $100.00 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 02/26/2024 | SANOFI PASTEUR INC. | — | — | Cash or cash equivalent | $16.59 | Research |
| Study: A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | ||||||
| 08/17/2023 | ModernaTX, Inc. | — | Travel and Lodging | In-kind items and services | $711.41 | General |
| 08/17/2023 | ModernaTX, Inc. | — | Food and Beverage | In-kind items and services | $517.85 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase I/II Study to Investigate the Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccines MRT5421, MRT5424, and MRT5429 in Healthy Participants Aged 18 Years and Above | SANOFI PASTEUR INC. | $2,046 | 14 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 13 | 14 | $2,212 | $321.25 |
Total Patients
13
Total Services
14
Medicare Billing
$321.25
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $2,212 | $321.25 | 14.5% |
About Roni Gray, APRN
Roni Gray, APRN is a Family healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1952445702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Roni Gray, APRN has received a total of $6,528 in payments from pharmaceutical and medical device companies, with $3,568 received in 2024. These payments were reported across 33 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($3,219).
As a Medicare-enrolled provider, Gray has provided services to 13 Medicare beneficiaries, totaling 14 services with total Medicare billing of $321.25. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Omaha, NE
- Active Since 02/16/2007
- Last Updated 08/05/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1952445702
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Omaha
Stephanie Simon, Aprn, APRN
Family — Payments: $154,278
Family $154,278
Laura Falcone, Aprn, APRN
Family — Payments: $25,682
Family $25,682
Ladeana Smedlund, Aprn, APRN
Family — Payments: $20,139
Family $20,139
Ms. Christina Hadley, Aprn Np-C, APRN NP-C
Family — Payments: $10,623
Family $10,623
Sara Legleiter, Aprn, APRN
Family — Payments: $9,281
Family $9,281
Brittany Matney, Dnp-Fnp, DNP-FNP
Family — Payments: $9,196
Family $9,196